A recent study indicates that patients who stop using blockbuster slimming jabs like Mounjaro or Wegovy tend to recover shed pounds much more quickly than those who stop traditional lifestyle programs.
Research printed in a prominent medical journal shows that while overweight people often shed substantial amounts of their total mass while on the medication, the mass returns at an average rate of 0.8 kg per month upon discontinuation.
"Users purchasing these drugs need to be aware of the danger of fast rebound weight gain when the therapy ends," stated expert Dr. Susan Jebb.
Such speed of recovery suggests a return to pre-treatment mass within about a year and a half.
Analyzing Approaches
The research, which examined 37 of trials involving thousands of participants, compared the effects of these new drugs with conventional dieting.
Scientists emphasize that individuals who shed pounds through lifestyle changes alone usually experience a more gradual creep back—perhaps 0.1 kg a month—once they finish.
Explaining the Quick Rebound
Experts suggest the way of the drugs explains the amplified rebound.
The injections copy a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Long-term administration of GLP-1 concentrations far above than the body's typical production might result in the system to generate a reduced amount of its own natural GLP-1, and may also lessen sensitivity to its actions," said Dr. Adam Collins, a nutrition expert.
"Discontinuation of this GLP-1 'fix' means appetite is unsuppressed, making excessive eating far more likely."
A Chronic Condition?
Health authorities advise the jabs for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.
A number of clinicians contend that, given the significant potential of weight regain, the therapy might need to be life-long.
This view is echoed by drug manufacturers, who state that the findings "underscore the chronic character of obesity," comparing it to managing diseases like hypertension.
User Accounts
Users who have discontinued the medication report a intense return of appetite.
"It felt as if a trigger flipping and you're instantly extremely hungry," recalled a patient.
This difficulty is exacerbated if patients have not developed sustainable dietary or behavioural changes during therapy.
Significant Use
Survey data show that millions of people in the UK have used weight-loss jabs in the past year, with desire continuing to grow.
- Adoption is greater among women compared to males.
- The middle-aged demographic shows the highest level of interest.
- Many access the drugs through private prescriptions rather than public health services.
Ultimately, clinicians emphasize that while these medications are effective agents for weight loss, they are not a magic solution and lasting health benefits relies on integrated lifestyle management.
